| Title |
A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma
|
|---|---|
| Published in |
Investigational New Drugs, October 2006
|
| DOI | 10.1007/s10637-006-9014-7 |
| Pubmed ID | |
| Authors |
Richard Kefford, Jane McNeil Beith, Guy Arthur Van Hazel, Michael Millward, James Marshall Trotter, David Keith Wyld, Rada Kusic, Revati Shreeniwas, Adele Morganti, Andrea Ballmer, Eleonor Segal, Oliver Nayler, Martine Clozel |
Mendeley readers
The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 45 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 22% |
| Student > Master | 7 | 16% |
| Other | 6 | 13% |
| Student > Doctoral Student | 5 | 11% |
| Student > Ph. D. Student | 5 | 11% |
| Other | 6 | 13% |
| Unknown | 6 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 22% |
| Agricultural and Biological Sciences | 10 | 22% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 11% |
| Biochemistry, Genetics and Molecular Biology | 3 | 7% |
| Nursing and Health Professions | 2 | 4% |
| Other | 7 | 16% |
| Unknown | 8 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2015.
All research outputs
#7,531,972
of 22,982,639 outputs
Outputs from Investigational New Drugs
#327
of 1,173 outputs
Outputs of similar age
#23,407
of 67,105 outputs
Outputs of similar age from Investigational New Drugs
#3
of 6 outputs
Altmetric has tracked 22,982,639 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,173 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 67,105 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.